Sigilon Revenue and Competitors

Boston, MA USA

Location

$263.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sigilon's estimated annual revenue is currently $11.4M per year.(i)
  • Sigilon's estimated revenue per employee is $126,333
  • Sigilon's total funding is $263.2M.
  • Sigilon's current valuation is $68.5M. (January 2022)

Employee Data

  • Sigilon has 90 Employees.(i)
  • Sigilon grew their employee count by -25% last year.

Sigilon's People

NameTitleEmail/Phone
1
Chief Legal OfficerReveal Email/Phone
2
VP FinanceReveal Email/Phone
3
Head Supply ChainReveal Email/Phone
4
VP, Head Bioanalytical & CMC Analytical DevelopmentReveal Email/Phone
5
Chief Business OfficerReveal Email/Phone
6
Associate EngineerReveal Email/Phone
7
Associate ScientistReveal Email/Phone
8
Principle Associate ScientistReveal Email/Phone
9
Associate ScientistReveal Email/Phone
10
Assistant EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Sigilon?

Harnessing the full power of cell therapeutics. Cambridge, MA

keywords:N/A

$263.2M

Total Funding

90

Number of Employees

$11.4M

Revenue (est)

-25%

Employee Growth %

$68.5M

Valuation

N/A

Accelerator

Sigilon News

2022-04-17 - Sigilon Therapeutics, Inc. (NASDAQ:SGTX) Given Consensus ...

Sigilon Therapeutics, Inc. (NASDAQ:SGTX) Given Consensus Rating of “Buy” by Brokerages. Posted by admin on Apr 22nd, 2022.

2022-03-30 - How Will the Market React to Sigilon Therapeutics Inc (SGTX) Stock Getting a Bullish Rating

The market has been high on Sigilon Therapeutics Inc (SGTX) stock recently. SGTX gets a Bullish score from InvestorsObserver Stock Sentiment...

2022-03-22 - Sigilon Therapeutics Reports Fourth Quarter and Full Year ...

Sigilon Therapeutics seeks to develop functional cures for patients with a broad range of chronic diseases by harnessing the power of the human...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.1M90-20%$987M
#2
$13.1M908%N/A
#3
$31.7M9034%N/A
#4
$14M9029%N/A
#5
$12.7M911%N/A